Banerjee S, Master R, Iqbal A, Brilakis E S
VA North Texas Healthcare System, Washington, DC, USA.
Minerva Cardioangiol. 2011 Jun;59(3):235-8.
Drug eluting stents (DES) have improved percutaneous coronary intervention (PCI) outcomes for most coronary lesion subsets and have gained widespread acceptance. This practice is supported by large-scale clinical trials. Evidence for DES use for treatment of saphenous vein graft (SVG) lesions is less well defined and often conflicting. Most SVG interventions are performed in the setting of an acute coronary syndrome (ACS), in large caliber vascular conduits with soft and friable plaque with inflammatory debris, without a fibrous cap. In this review, we provide an up to date assessment of the published evidence on DES use in PCI of SVG lesions.
药物洗脱支架（DES）已改善了大多数冠状动脉病变亚组的经皮冠状动脉介入治疗（PCI）效果，并获得了广泛认可。这种做法得到了大规模临床试验的支持。关于DES用于治疗大隐静脉桥血管（SVG）病变的证据尚不明确，且常常相互矛盾。大多数SVG介入治疗是在急性冠状动脉综合征（ACS）的情况下进行的，病变位于大口径血管管道内，斑块柔软且易碎，伴有炎性碎片，无纤维帽。在本综述中，我们对已发表的关于DES用于SVG病变PCI的证据进行了最新评估。
